|1.||Johansson, Martin: 3 articles (06/2014 - 02/2008)|
|2.||Hellsten, Rebecka: 3 articles (06/2014 - 02/2008)|
|3.||Sterner, Olov: 3 articles (06/2014 - 02/2008)|
|4.||Bjartell, Anders: 3 articles (06/2014 - 02/2008)|
|5.||Dahlman, Anna: 2 articles (01/2011 - 02/2008)|
|6.||Jurk, Kerstin: 1 article (01/2015)|
|7.||Bollmann, Franziska: 1 article (01/2015)|
|8.||Kleinert, Hartmut: 1 article (01/2015)|
|9.||Jäckel, Sven: 1 article (01/2015)|
|10.||Walter, Ulrich: 1 article (01/2015)|
|1.||Prostatic Neoplasms (Prostate Cancer)
01/01/2011 - "In this study we aimed to investigate the effect of galiellalactone on prostate cancer stem cell-like cells. "
06/06/2014 - "The fungal metabolite galiellalactone, a STAT3 signaling inhibitor, inhibits the growth, both in vitro and in vivo, of prostate cancer cells expressing active STAT3 and induces apoptosis of prostate cancer stem cell-like cells expressing phosphorylated STAT3 (pSTAT3). "
01/01/2011 - "These findings emphasize that targeting the STAT3 pathway in prostate cancer cells, including prostate cancer stem cell-like cells, is a promising therapeutic approach and that galiellalactone is an interesting compound for the development of future prostate cancer drugs."
01/01/2011 - "Galiellalactone treatment decreased the proportion of ALDH+ prostate cancer cells and induced apoptosis of ALDH+ cells. "
01/01/2011 - "Galiellalactone is a potent and specific inhibitor of STAT3 signaling which has been shown to possess growth inhibitory effects on prostate cancer cells expressing active STAT3. "
|1.||STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)